Filter by Year: ALL 2024 2023 2022 2021 2020 2019 2018 Dec 13, 2018 Foghorn® Therapeutics appoints Carl P. Decicco, Ph.D. as Chief Scientific Officer Mar 14, 2018 Flagship Pioneering Launches Foghorn Therapeutics With Initial Capital Commitment of $50 Million
